SSS.V Will Be $1 Soon
posted on
Jan 24, 2010 12:17PM
Stem Cell is a public biotechnology company focused on the development and commercialization of drug-based therapies to treat central nervous system diseases.
Hi everyone, I have held shares in Stem Cell Therapeutics for almost a year. I started buying in @ .08 cents and have built on my position considerably since then after doing more intense Due Diligence!
I was in attendance for the Nov 26 'From the Lab to the Bedside' seminar and it was very informative w/a full house!
| 
  Q1 10  
 | 
 Complete patient enrollment in modified REGENESIS Phase IIb acute ischemic stroke trial 
 | 
| 
  Q2 10  
 | 
 Report Top-line modified REGENESIS Phase IIb stroke trial data 
 | 
| 
  H1 10  
 | 
 Initiate and enrol patients in a Phase IIa clinical study for traumatic brain injury 
 | 
| 
  H2 10  
 | 
 Initiate clinical Proof-of-Concept study for multiple sclerosis 
 | 
| 
  H2 10  
 | 
 Complete preclinical study for hemorrhagic stroke 
 | 
| 
  H2 10  
 | 
 Complete 'end of Phase II' meeting with the FDA prior to initiating the Phase III stroke trial 
 |